Rybelsus tablets (semaglutide) er en receptpligtig medicin, der bruges til voksne med type 2-diabetes mellitus for at sænke blodsukkerniveauet. Rybelsus kan ordineres, når andre diabetesmedicin er blevet forsøgt uden succes og bør bruges sammen med kost og motion. Rybelsus tabletter arbejder for at sænke blodsukkerniveauet (glukose) ved at øge, hvor meget insulin der frigives, og mindske glucagon sekretionen. Denne medicin kan også bremse gastrisk tømning efter at have spist.
3mg
Pakke
Besparelser
Per tablet
Pris
Bestilling
90 tabletter
kr 2981.03
kr 99.45
kr 8950.71
Gratis Luftpostforsendelse
60 tabletter
kr 1589.64
kr 106.08
kr 6364.85
Gratis Luftpostforsendelse
30 tabletter
kr 596.07
kr 112.71
kr 3381.17
Gratis Luftpostforsendelse
20 tabletter
kr 264.88
kr 119.33
kr 2386.61
Gratis Luftpostforsendelse
10 tabletter
kr 132.57
kr 1325.75
Gratis Luftpostforsendelse
7mg
Pakke
Besparelser
Per tablet
Pris
Bestilling
90 tabletter
kr 1190.82
kr 119.34
kr 10740.92
Gratis Luftpostforsendelse
60 tabletter
kr 595.08
kr 122.66
kr 7359.41
Gratis Luftpostforsendelse
30 tabletter
kr 198.25
kr 125.97
kr 3779.00
Gratis Luftpostforsendelse
20 tabletter
kr 65.97
kr 129.28
kr 2585.52
Gratis Luftpostforsendelse
10 tabletter
kr 132.57
kr 1325.75
Gratis Luftpostforsendelse
14mg
Pakke
Besparelser
Per tablet
Pris
Bestilling
90 tabletter
kr 1489.19
kr 142.55
kr 12829.49
Gratis Luftpostforsendelse
60 tabletter
kr 793.99
kr 145.86
kr 8751.80
Gratis Luftpostforsendelse
30 tabletter
kr 297.70
kr 149.17
kr 4475.19
Gratis Luftpostforsendelse
20 tabletter
kr 132.28
kr 152.48
kr 3049.65
Gratis Luftpostforsendelse
10 tabletter
kr 159.10
kr 1590.96
Gratis Luftpostforsendelse
Rybelsus® tablets
What is Rybelsus?
Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.
Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.
Warnings
You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.